BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shih AR, Murali MR. Laboratory tests for disorders of complement and complement regulatory proteins. Am J Hematol 2015;90:1180-6. [PMID: 26437749 DOI: 10.1002/ajh.24209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lanza F. Issue Highlight - July 2018. Cytometry B Clin Cytom 2018;94:557-60. [PMID: 30134072 DOI: 10.1002/cyto.b.21644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Blasco M, Guillén E, Quintana LF, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J 2021;14:1055-66. [PMID: 33841853 DOI: 10.1093/ckj/sfaa195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kerboua KE, Djenouhat K. Semi-solid phase assay for the alternative complement pathway activity assessment (AP100). J Immunoassay Immunochem 2020;41:144-51. [PMID: 31771421 DOI: 10.1080/15321819.2019.1696819] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, Seppänen MRJ, Sullivan KE, Jolles S. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol 2020;40:576-91. [PMID: 32064578 DOI: 10.1007/s10875-020-00754-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
5 Vercauteren KOA, Lambrecht S, Delanghe J. Preanalytical classical and alternative complement pathway activity loss. Biochem Med (Zagreb) 2019;29:030701. [PMID: 31379459 DOI: 10.11613/BM.2019.030701] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Cheng G, Ozgonenel B, Bhambhani K, Kapur G, Smith RJ, Savaşan S. Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy. J Pediatr Hematol Oncol 2018;40:560-2. [PMID: 28991131 DOI: 10.1097/MPH.0000000000000987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Iorember F, Nayak A. Deficiency of CFHR plasma proteins and autoantibody positive hemolytic uremic syndrome: treatment rationale, outcomes, and monitoring. Pediatr Nephrol 2021;36:1365-75. [PMID: 32529325 DOI: 10.1007/s00467-020-04652-x] [Reference Citation Analysis]